Seven Grand Managers LLC Trims Stock Position in Hinge Health Inc. $HNGE

Seven Grand Managers LLC cut its stake in Hinge Health Inc. (NYSE:HNGE) by 20.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 200,000 shares of the company’s stock after selling 50,000 shares during the period. Seven Grand Managers LLC’s holdings in Hinge Health were worth $9,290,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Hinge Health in the third quarter valued at $37,000. First Horizon Corp lifted its position in Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock valued at $40,000 after acquiring an additional 531 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in Hinge Health in the third quarter valued at $49,000. High Point Wealth Management LLC purchased a new stake in Hinge Health in the fourth quarter valued at $46,000. Finally, Jones Financial Companies Lllp lifted its position in Hinge Health by 348.0% in the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock valued at $54,000 after acquiring an additional 870 shares during the last quarter.

Analyst Ratings Changes

A number of research analysts have commented on HNGE shares. Needham & Company LLC lifted their price objective on shares of Hinge Health from $59.00 to $63.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Zacks Research upgraded shares of Hinge Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 13th. KeyCorp set a $55.00 price objective on shares of Hinge Health in a research note on Wednesday, February 11th. Evercore restated an “outperform” rating and issued a $45.00 price objective on shares of Hinge Health in a research note on Wednesday, April 8th. Finally, Barclays lifted their price objective on shares of Hinge Health from $52.00 to $62.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $67.40.

Insiders Place Their Bets

In related news, President James Pursley sold 16,000 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $53.79, for a total transaction of $860,640.00. Following the transaction, the president owned 780,223 shares of the company’s stock, valued at $41,968,195.17. This represents a 2.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Antonio Perez sold 45,456 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $55.05, for a total value of $2,502,352.80. Following the completion of the transaction, the chief executive officer owned 35,470 shares of the company’s stock, valued at $1,952,623.50. The trade was a 56.17% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 587,932 shares of company stock valued at $29,116,997 in the last three months. 18.92% of the stock is owned by corporate insiders.

Hinge Health Stock Performance

NYSE HNGE opened at $53.49 on Thursday. The firm has a market cap of $4.14 billion and a PE ratio of -4.33. Hinge Health Inc. has a one year low of $30.08 and a one year high of $62.18. The firm’s fifty day moving average is $45.61 and its two-hundred day moving average is $44.52.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The business had revenue of $182.31 million for the quarter. During the same quarter last year, the firm earned $1.30 earnings per share. The company’s revenue was up 47.2% compared to the same quarter last year. Research analysts predict that Hinge Health Inc. will post 1.21 earnings per share for the current year.

Hinge Health Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.